The heterodimeric structure of heterogeneous nuclear ribonucleoprotein C1/C2 dictates 1,25-dihydroxyvitamin D-directed transcriptional events in osteoblasts

Bone Research

Volumn 2, Issue , 2014, Pages

  Lisse, Thomas S ^a,b   Vadivel, Kanagasabai ^a   Bajaj, S Paul ^a   Zhou, Rui ^a   Chun, Rene F ^a   Hewison, Martin ^a   Adams, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT DESERT ISLAND BIOLOGICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85030451065     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2014.11     Document Type: Article

References (40)

1. Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013; 78: 127-136.
2. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D3. Rheum Dis Clin North Am 2012; 38: 13-27.
3. Haussler MR, Whitfield GK, Kaneko I et al. Molecular mechanisms of vitamin d action. Calcif Tissue Int 2013; 92: 77-98.
4. Haussler MR, Haussler CA, Whitfield GK et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the ''Fountain of Youth'' tomediate healthful aging. J Steroid Biochem Mol Biol 2010; 121: 88-97.
5. ChenH,Hu B,Allegretto EA, Adams JS. The vitaminDresponse elementbinding protein. A novel dominant-negative regulator of vitamin Ddirected transactivation. J Biol Chem 2000; 275: 35557-35564.
6. Adams JS, Chen H, Chun RF et al. Novel regulators of vitamin D action and metabolism: lessons learned at the Los Angeles zoo. J Cell Biochem 2003; 88: 308-314.
7. Chen H, Hewison M, Hu B, Adams JS. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci USA 2003; 100: 6109-6114.
8. Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element-binding protein. J Biol Chem 2006; 281: 39114-39120.
9. Lisse TS, Hewison M, Adams JS. Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling. Steroids 2011; 76: 331-339.
10. Krecic AM, SwansonMS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999; 11: 363-371.
11. Carpenter B, MacKay C, Alnabulsi A et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006; 1765: 85-100.
12. Dreyfuss G. Structure and function of nuclear and cytoplasmic ribonucleoprotein particles. Annu Rev Cell Biol 1986; 2: 459-498.
13. Nakagawa TY, Swanson MS, Wold BJ, Dreyfuss G. Molecular cloning of cDNA for the nuclear ribonucleoprotein particle C proteins: a conserved gene family. Proc Natl Acad Sci USA 1986; 83: 2007-2011.
14. Merrill BM, Barnett SF, LeStourgeon WM, Williams KR. Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles. Nucleic Acids Res 1989; 17: 8441-8449.
15. Mahajan MC, Narlikar GJ, Boyapaty G, Kingston RE, Weissman SM. Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region. Proc Natl Acad Sci USA 2005; 102: 15012-15017.
16. Irimura S, Kitamura K, Kato N et al. HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1. Kobe J Med Sci 2009; 54: E227-E236.
17. Izquierdo JM. Heterogeneous ribonucleoprotein C displays a repressor activity mediated by T-cell intracellular antigen-1-related/like protein to modulate Fas exon 6 splicing through amechanism involvingHu antigen R. Nucleic Acids Res 2010; 38: 8001-8014.
18. Shetty S. Regulation of urokinase receptormRNAstability by hnRNPCin lung epithelial cells. Mol Cell Biochem 2005; 272: 107-118.
19. McCloskey A, Taniguchi I, Shinmyozu K, Ohno M. hnRNP C tetramer measures RNA length to classify RNA polymerase II transcripts for export. Science 2012; 335: 1643-1646.
20. Lisse TS, Liu T, Irmler M et al. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. Faseb J 2011; 25: 937-947.
21. Lisse TS, Hewison M. Vitamin D: a new player in the world of mTOR signaling. Cell Cycle 2011; 10: 1888-1889.
22. Lisse TS, Hewison M, Adams JS. Hormone response element binding proteins: Novel regulators of vitamin D and estrogen signaling. Steroids 2011; 76: 331-339.
23. Adams JS, Chen H, Chun R et al. Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism. J Steroid Biochem Mol Biol 2004; 89/90: 461-465.
24. Chen H, Arbelle JE, Gacad MA, Allegretto EA, Adams JS. Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element. J Clin Invest 1997; 99: 669-675.
25. Soneoka Y, Cannon PM, Ramsdale EE et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
26. Chen C, OkayamaH.High-efficiency transformation ofmammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752.
27. Whitson SR, LeStourgeon WM, Krezel AM. Solution structure of the symmetric coiled coil tetramer formed by the oligomerization domain of hnRNP C: implications for biological function. J Mol Biol 2005; 350: 319-337.
28. Phillips JC, Braun R, Wang W et al. Scalable molecular dynamics with NAMD. J Comput Chem 2005; 26: 1781-1802.
29. Brooks BR, Brooks CL 3rd, Mackerell AD Jr et al. CHARMM: the biomolecular simulation program. J Comput Chem 2009; 30: 1545-1614.
30. Case DA, Cheatham TE 3rd, Darden T et al. The Amber biomolecular simulation programs. J Comput Chem 2005; 26: 1668-1688.
31. de Felipe P, Martin V, Cortes ML, Ryan M, Izquierdo M. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Ther 1999; 6: 198-208.
32. Kim JH, Lee SR, Li LH et al. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS ONE 2011; 6: e18556.
33. Liu J, Zheng Q, Deng Y et al. A seven-helix coiled coil. Proc Natl Acad Sci USA 2006; 103: 15457-15462.
34. Burd CG, Dreyfuss G.RNAbinding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 1994; 13: 1197-1204.
35. Swanson MS, Nakagawa TY, LeVan K, Dreyfuss G. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol Cell Biol 1987; 7: 1731-1739.
36. McAfee JG, Shahied-Milam L, Soltaninassab SR, LeStourgeon WM. A major determinant of hnRNP C protein binding to RNA is a novel bZIP-like RNA binding domain. RNA 1996; 2: 1139-1152.
37. Shahied L, Braswell EH, LeStourgeon WM, Krezel AM. An antiparallel four-helix bundle orients the high-affinityRNAbinding sites in hnRNP C: a mechanism for RNA chaperonin activity. J Mol Biol 2001; 305: 817-828.
38. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 1994; 265: 615-621.
39. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993; 62: 289-321.
40. Takimoto M, Tomonaga T, Matunis M et al. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J Biol Chem 1993; 268: 18249-18258.